Misdiagnosis could become a thing of the past. With advanced artificial intelligence (AI), 15 years of medical research and perseverance, Symptoma, a world-leading accurate online symptom checker, is reducing one of medicine’s biggest blind spots. One in seven diagnoses are incorrect and eliminating this problem could save 1.5 million lives every year.

New relationship will offer opportunities for SMEs to establish partnerships with corporate venturing teams, in cooperation with the EU-funded InvestHorizon1 programme.

Why Eurostars is an essential component of Horizon Europe.

Insights

1. Horizon Europe emphasises the need to reinforce support to SMEs for the research and development of emerging and breakthrough innovations. There is a need for policies directly targeting SMEs and that aim to close the innovation gap in the European Union.
2. The Innovative SMEs Partnership delivers a unique 1:3 leverage cash effect on EU funds. The total leverage effect, including private and public funds, is 1:7.
3. The new strategy for the European Research Area (ERA) recommends member countries allocate a target of 5% R&D expenditure to international funding programmes[1].
4. The final allocation of funds from Horizon Europe to the Innovative SMEs Partnership should be proportionate to the budgetary situation of the Framework Programme.
5. Eureka considers an allocation of 300 M€ to the Innovative SMEs Partnership to be an optimal balance between diversity of European interests and sharing the burden of budget cuts, while ensuring the viability of a funding programme with a proven track record for creating jobs and growth.